|
Characteristics
|
Total
|
CTC pos
|
In %
|
P-value
|
|---|
|
Total
|
502
|
97
|
19
|
-
|
|
Tumor Size
| | | | |
|
pT1
|
322
|
58
|
18
|
0.32
|
|
pT2-4
|
180
|
39
|
22
| |
|
Nodal Status
| | | | |
|
Negative
|
340
|
65
|
19
|
0.79
|
|
Positive
|
159
|
32
|
20
| |
|
Histology
| | | | |
|
Ductal
|
392
|
78
|
20
|
0.83
|
|
Lobular
|
77
|
13
|
17
| |
|
Others
|
30
|
6
|
20
| |
|
Grading
| | | | |
|
G I
|
95
|
18
|
19
|
0.68
|
|
G II
|
290
|
53
|
18
| |
|
G III
|
113
|
25
|
22
| |
|
ER status
| | | | |
|
Positive
|
415
|
77
|
19
|
0.34
|
|
Negative
|
87
|
20
|
23
| |
|
PR status
| | | | |
|
Positive
|
382
|
72
|
19
|
0.63
|
|
Negative
|
120
|
25
|
21
| |
|
HER2 status
| | | | |
|
Negative
|
437
|
83
|
19
|
0.50
|
|
Positive
|
62
|
14
|
23
| |
|
DTC
| | | | |
|
Negative
|
367
|
69
|
19
|
0.41
|
|
Positive
|
107
|
24
|
21
| |
|
Subtype by IHC
| | | | |
|
(ER-, PR-, HER2-)
|
58
|
14
|
24
|
0.62
|
|
(ER-, PR-, HER2+)
|
17
|
3
|
18
| |
|
(ER+ and/or PR+)
|
424
|
80
|
19
| |
